A

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Senior Manager - Integrated Quality Operations

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeVerona, WI, USA$150k - $165k

About the Job

Requirements

  • A bachelor's degree in a science field and at least 10 years of pharmaceutical or biotechnology quality assurance experience supporting GMP operations for clinical and/or commercial products are required.
  • Direct experience with material and product disposition, including raw material release, batch record review, and release of drug substance or drug product, is required.
  • Demonstrated experience serving as a quality subject matter expert for deviations, investigations, out of specification/out of trend results, root cause analysis, and corrective and preventive action is required.
  • Experience with specification setting and management and with review and trending of stability data is required.
  • Working knowledge of United States and international GMP regulations and guidance applicable to investigational and commercial products, including phase-appropriate GMP application, is required.
  • Experience developing, implementing, and maintaining compliance systems and procedures is required.
  • Demonstrated leadership of projects and/or personnel to complete assigned duties is required.
  • Ability to represent Quality with external partners and senior management and communicate with diverse professionals is required.
  • Ability to travel domestically and internationally up to 20% for partner oversight and audits is required.
  • Candidates must have current, valid authorization to work in the country where the role is located.

Responsibilities

  • Lead the GMP Operations Quality Assurance team supporting early-phase, late-phase, and commercial programs, including hiring, management, mentoring, performance management, and workload planning.
  • Provide GMP quality oversight using phase-appropriate requirements for programs spanning clinical and commercial supply, including nonconformances and out-of-specification results.
  • Own QA release of GMP raw materials, including review of supplier documentation and certificates of analysis, incoming inspection and testing records, and compendial and regulatory compliance; make final raw-material disposition decisions.
  • Own QA review and approval of the release and stability program, including release and stability protocols and reports, QA data review, stability out-of-specification/out-of-trend results, retest-date and expiry assignment and extensions, and stability commitments supporting regulatory filings and ongoing supply.
  • Own specification lifecycle management for intermediates, drug substance, and drug product, including creation, review, approval, periodic review, and version control; collaborate with regulatory, CMC, and analytical development stakeholders to ensure acceptance criteria are phase-appropriate, appropriately tightened as programs progress, and aligned with filed commitments and compendial requirements.
  • Serve as the subject matter expert and process owner for quality events, including deviations, investigations, out-of-specification/out-of-trend results, root cause analysis, product-impact and quality assessments, corrective and preventive action, effectiveness checks, and change control; coach investigation owners, approve investigation quality and conclusions, and escalate significant issues as necessary.
  • Maintain inspection readiness and support health authority inspections and partner audits covering GMP operations for clinical and commercial products.
  • Collaborate with and provide quality support to other departments, including CMC, Manufacturing, Analytical Development/Quality Control, Supply Chain, Regulatory Affairs, Clinical Operations, Project Management, and Toxicology.
  • Organize and control quality, compliance, and project-related documentation, including GMP record retention within the electronic quality management system.
  • Develop, track, and report GMP operations quality metrics, including material release, quality-event and corrective-action aging, and right-first-time performance; present quality performance and risks to management.
  • Write, review, update, approve, issue, and organize applicable procedural documents, including standard operating procedures, work instructions, test methods, policies, and forms; drive continuous improvement of quality systems as programs progress from clinical to commercial operations.
  • Maintain knowledge of current compliance expectations and regulations for investigational and commercial products, including 21 CFR Parts 210/211, ICH Q1A(R2), Q6A/Q6B, Q7–Q12, EU GMP and applicable annexes, GDP, and USP/Ph. Eur. compendial requirements.
  • Perform other duties consistent with the position as assigned.

Desired Qualifications

  • An advanced degree in a science field is preferred.
  • Previous people-management experience, including hiring and developing QA staff, is preferred.
  • Experience supporting a commercial launch and/or an NDA/BLA/MAA submission and pre-approval inspection is preferred.
  • Experience managing quality events through the transition from early phase into late phase and commercial supply is preferred.
  • Working knowledge of compendial requirements (USP, Ph. Eur., JP) and compendial change monitoring is preferred.
  • Formal training in structured root cause analysis and investigation methodology is preferred.
  • Experience with sterile/parenteral drug product and oligonucleotide, peptide, or biologic modalities is preferred.
  • Experience with electronic quality management, document control, and laboratory information management systems (e.g., Veeva Vault, TrackWise, MasterControl, LIMS) is preferred.
  • Additional Quality/Regulatory-related certification, such as CQA, CQMP, or RAC, is desired.

About the Company

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Arrowhead Pharmaceuticals develops medicines using RNA interference (RNAi) to silence disease-causing genes. The company’s approach uses a library of RNA chemistries and delivery methods to trigger RNAi, enabling rapid and durable reduction of target gene expression in cells. This gene-silencing strategy aims to treat severe genetic diseases such as cystic fibrosis and hepatitis B by lowering disease-related proteins. Arrowhead’s products are advanced through discovery and development partnerships, licensing deals, and potential commercialization of approved therapies. The company differentiates itself through a broad RNAi platform, proprietary delivery tech, and collaborations with larger pharma firms to advance its pipeline. Its goal is to provide new treatment options for conditions with limited or no effective therapies by translating gene silencing into medicines that can halt or reverse disease progression.

Company size
501-1,000
Company stage
IPO
Headquarters
Pasadena, CA
Founded
2004

Recently Posted Jobs

Explore more opportunities at Arrowhead Pharmaceuticals

See more jobs